Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up

BACKGROUND: Diabetic foot ulcer (DFU) is a serious chronic complication of diabetes mellitus that contributes to 85% of nontraumatic lower extremity amputations in diabetic patients. Preliminary clinical benefits have been shown in treatments based on mesenchymal stem cells for patients with DFU or...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Che, Huang, Li, Wang, Xiaofen, Zhou, Xiaoya, Zhang, Xiaoxian, Li, Ling, Wu, Jieying, Kou, Meng, Cai, Cheguo, Lian, Qizhou, Zhou, Xihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446755/
https://www.ncbi.nlm.nih.gov/pubmed/36064461
http://dx.doi.org/10.1186/s13287-022-03143-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446755/
https://www.ncbi.nlm.nih.gov/pubmed/36064461
http://dx.doi.org/10.1186/s13287-022-03143-0

Ejemplares similares